Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients

Abstract

ILD and GLD, although rare, can cause significant morbidity. In our series, over half of cases were drug-related and therefore focused pharmacovigilance is needed to identify and manage these cases.